SLRX - Salarius Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts0001
Avg. Estimate000-1.98
Low Estimate000-1.98
High Estimate000-1.98
Year Ago EPS-13.5-11.5N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate251k163k838k3.33M
Low Estimate200k300k900k3.33M
High Estimate200k300k900k3.33M
Year Ago Sales407k283k1.27M838k
Sales Growth (year/est)-38.30%-42.40%-34.30%297.40%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-15.12-14.25-12.12-11.25
EPS Actual-13.5-11.5-11.5-12.5
Difference1.622.750.62-1.25
Surprise %10.70%19.30%5.10%-11.10%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate000-1.98
7 Days Ago-0.25-0.13-1.32-1.98
30 Days Ago-0.25-0.13-1.32-1.98
60 Days Ago-0.25-0.13-1.32-0.27
90 Days Ago-0.25-0.13-1.32-0.27
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSLRXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.01
Next Qtr.N/AN/AN/A0.06
Current YearN/AN/AN/A-0.02
Next YearN/AN/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A